UPDATED May 19, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SPOT | US$302.82 | 2.8% | 102.7% | US$60.1b | US$336.35 | PS4x | E40.3% | n/a | Media | ||
NEON | US$2.20 | -18.1% | -70.5% | US$33.8m | US$3.00 | PS8x | E158.0% | n/a | Tech | ||
WULF | US$1.95 | -12.6% | 25.0% | US$649.7m | US$3.62 | PS6.5x | E146.5% | n/a | Software | ||
MP | US$18.25 | 13.1% | -14.2% | US$3.0b | US$24.18 | PE900.9x | E61.9% | n/a | Materials | ||
SMWB | US$7.82 | 11.2% | 48.7% | US$628.0m | US$10.40 | PS2.8x | E107.1% | n/a | Software | ||
MYO | US$3.64 | -5.0% | 717.4% | US$104.8m | US$6.50 | PS5.4x | E64.8% | n/a | Healthcare | ||
CVCY | US$19.89 | 3.6% | -1.1% | US$235.3m | US$23.75 | PB1.1x | E39.8% | 2.4% | Banks | ||
CIFR | US$3.85 | 3.5% | 52.2% | US$1.2b | US$5.83 | PE63.9x | E16.3% | n/a | Software | ||
BFRI | US$1.07 | -15.1% | -89.7% | US$5.4m | US$16.00 | PE-0.2x | E67.7% | n/a | Pharmaceuticals & Biotech | ||
LNKB | US$6.62 | 1.4% | 29.5% | US$247.2m | US$8.17 | PB0.9x | E87.4% | 4.5% | Banks | ||
FTCI | US$0.50 | 7.1% | -83.8% | US$62.9m | n/a | PB1.1x | E74.9% | n/a | Capital Goods | ||
TBPH | US$9.29 | -1.0% | -17.1% | US$451.8m | US$15.40 | PS7.3x | E66.3% | n/a | Pharmaceuticals & Biotech | ||
CBAT | US$1.27 | 11.4% | 60.8% | US$114.2m | US$2.50 | PE13x | E56.6% | n/a | Capital Goods | ||
BYRN | US$11.71 | -12.7% | 124.3% | US$266.2m | US$16.63 | PS5.2x | E109.7% | n/a | Capital Goods | ||
MBI | US$6.00 | -2.4% | -23.4% | US$307.7m | US$9.17 | PE-0.6x | E152.0% | n/a | Insurance | ||
LVO | US$1.83 | 1.7% | 21.6% | US$174.3m | US$4.75 | PS1.5x | E94.4% | n/a | Media | ||
TEAM | US$179.72 | -0.02% | 22.3% | US$46.8b | US$240.61 | PS11.2x | E41.3% | n/a | Software | ||
TOST | US$26.99 | 0.6% | 29.7% | US$15.0b | US$27.25 | PS3.6x | E63.0% | n/a | Diversified Financials | ||
IBTA | US$106.19 | 3.9% | n/a | US$3.2b | US$120.86 | PE84.6x | E46.6% | n/a | Media | ||
REE | US$4.99 | 16.9% | -56.2% | US$54.0m | US$13.50 | PS33.6x | E55.6% | n/a | Automobiles | ||
ALAB | US$72.50 | 3.5% | n/a | US$11.3b | US$87.73 | PS69.1x | E62.8% | n/a | Semiconductors | ||
VRCA | US$8.67 | 8.4% | 46.0% | US$367.8m | US$14.17 | PS41.3x | E65.9% | n/a | Pharmaceuticals & Biotech | ||
APP | US$82.49 | -4.6% | 228.4% | US$27.1b | US$93.24 | PE45.7x | E24.7% | n/a | Software | ||
VCTR | US$51.69 | 6.2% | 58.9% | US$3.3b | US$51.50 | PE15.2x | E30.6% | 2.9% | Diversified Financials |